Cyclo(-Gly-Arg-Gly-Asp-Ser-Pro) Trifluoroacetate

Cyclo(-Gly-Arg-Gly-Asp-Ser-Pro) Trifluoroacetate forms a stable cyclic peptide enriched with charged and polar residues. The ring constraint enhances resistance to conformational drift and aids binding-site modeling. Researchers study its interaction geometry and rigidity in solution. Use spans biomaterial design, adhesion-motif analysis, and structural optimization.

Designed for biological research and industrial applications, not intended for individual clinical or medical purposes.
Cyclo(-Gly-Arg-Gly-Asp-Ser-Pro) Trifluoroacetate(CAS 135432-37-0)

CAT No: R2649

CAS No:135432-37-0

Synonyms/Alias:135432-37-0;Cyclo(-Gly-Arg-Gly-Asp-Ser-Pro) Trifluoroacetate;DA-72465;Cyclo(-Gly-Arg-Gly-Asp-Ser-Pro) trifluoroacetate salt;2-[(3S,6S,12S,18S)-12-[3-(diaminomethylideneamino)propyl]-3-(hydroxymethyl)-2,5,8,11,14,17-hexaoxo-1,4,7,10,13,16-hexazabicyclo[16.3.0]henicosan-6-yl]acetic acid;2,2,2-trifluoroacetic acid;

Custom Peptide Synthesis
cGMP Peptide
  • Registration of APIs
  • CMC information required for an IND
  • IND and NDA support
  • Drug master files (DMF) filing
M.F/Formula
C24H36F3N9O11
M.W/Mr.
683.6
Sequence
Three Letter Code:cyclo[Arg-Gly-Asp-Ser-Pro-Gly].TFA
InChI
InChI=1S/C22H35N9O9.C2HF3O2/c23-22(24)25-5-1-3-11-18(37)26-8-16(34)29-12(7-17(35)36)19(38)30-13(10-32)21(40)31-6-2-4-14(31)20(39)27-9-15(33)28-11;3-2(4,5)1(6)7/h11-14,32H,1-10H2,(H,26,37)(H,27,39)(H,28,33)(H,29,34)(H,30,38)(H,35,36)(H4,23,24,25);(H,6,7)/t11-,12-,13-,14-;/m0./s1
InChI Key
GNFOUBGDKJPLPE-ZMNOQRQPSA-N

Useful Tools

Peptide Calculator

Abbreviation List

Peptide Glossary

If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.

Featured Services
Peptide Nucleic Acids SynthesiscGMP Peptide ServiceCustom Conjugation ServicePeptide Modification ServicesPeptide Analysis ServicesEpitope Mapping ServicesPeptide CDMOPeptide Synthesis Services
Hot Products
About us

Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.

From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.

Our Customers